1. The Mission of Fraunhofer Chile
Research
© Fraunhofer

2. Overview
• What is the Fraunhofer Gesellschaft
• What is Fraunhofer Chile Research
• What do we do in the Centre for Systems
Biotechnology
• How do we address Intellectual Property development
© Fraunhofer

3. Fraunhofer Gesellschaft
• Largest Applied Research Organisation in Europe
• 60 Institutes focussed on applied research
• 18000 employees
• Budget over 1.7bil Euros
• Over 1.4bil Euros in contract research funding
• Income from Industry 1.05bil Euros
• Supports Innovation for German Industry
• Institutes cover all aspects of industrial landscape
• Extensive IP estate and licensing income
© Fraunhofer

4. Institute Alliances Themes
•Microelectronics
•Production • Health
•Information,
• Security
Communication
•Materials and • Communication
Components • Mobility
•Surface technology, • Energy
Photonics
• Environment
•Defense research
•Life Sciences
© Fraunhofer

5. Applied Research
• Applied Research helps Industry with Innovation
• Focus on Industry needs
• Diverse range of projects ( single to multiple partners,
to large international networks)
• Internal research develops leading edge platform
technologies which allow industry to develop
innovative products
• IP Development and protection is key to competitive
advantage
© Fraunhofer

6. Applications at the German Patent and
Trade Mark Office
Ranking Applicant Country Applicants
1 Siemens AG DE 2 501
2 Robert Bosch GmbH DE 2 202
3 DaimlerChrysler AG DE 1 626
4 Inf ineon Technologies AG DE 1 236
5 Volksw agen AG DE 731
6 Denso Corp. JP 708
7 BASF AG DE 690
8 Bayerische M ot oren Werke AG DE 621
9 ZF Friedrichshaf en AG DE 545
10 Audi AG DE 411
11 Fraunhofer-Gesellschaft DE 396
12 BSH Bosch Siemens Hausgerät e DE 382
GmbH
13 Schaef f ler KG DE 371
14 Voit h Pat ent GmbH DE 335 Source: German

Patent
15 Henkel KGaA DE 265 and Trade Mark
Office
...
© Fraunhofer
ZV-P2/Mai 2009

7. Strategy
• Fraunhofer activities are closely linked to National
Innovation Strategies
• Internal analysis of both national and international
industry trends
• Close links with Universities provide reach into basic
research and future technologies
• Constantly changing project portfolios provide
adaptability to react to industries needs
© Fraunhofer

8. Identification of Novel Innovation Potentials Early On
Perspectives for Fraunhofer Markets for
Future Markets Frontline Themes tomorrow
Global Megatrends Grand societal challenges
1. consultation:
Foresight analyses and Fh-leaders Technology based
trend studies 170 topics problem solutions
50 Technology- 2. consultation: Mapping
trends Topic-ranking Fh-competences
Workshop with Expert interviews: Fraunhofer-
>50 experts 25 Focus-topics internal process
Perspec Future Tomorrow
-tives Topics Markets
12 12 5
2004 2005 2007 2008 2010 2011
© Fraunhofer

9. Fraunhofer Chile Research
• FCR established in 2010 as a Foundation
• Aim is to channel Fraunhofer Innovation Model to Chile
and other South American Countries
• Centre for Systems Biotechnology is first activity
• Contribute to exchange of technologies and personnel
between Germany and Chile
• Contribute to technical and human resources capacity
development in Chile
• Closely linked to Fraunhofer Institute for Molecular
Biology and Applied Ecology (IME)
© Fraunhofer

10. IME Molecular Biology Aachen
Avia-Luftbild, Aachen – Dipl.-Ing. Martin Jochum Mission:
Develop and apply cutting edge enabling technologies to assist
the diagnosis and treatment of human and animal diseases and
to protect food and feed stocks around the world

11. Fraunhofer IME
 Locations in Aachen, RWTH Aachen, Giessen, Muenster,
Schmallenberg, Neustadt, USA
 Total funds raised over Euro M200
 365 staff members (2009)
 Budget 40 M Euro (2010)
 37% Industry revenue
 Large patent estate through in-house activities and
collaborative projects

12. IME Business Fields
 Applied and functional genomics (target identification)
 Pharmaceutical product development (antibodies, vaccines)
 integrated production platforms
 Plant biotechnology
 Industrial biotechnology
 Insect biotechnology
 Systems biotechnology
 Ecotoxicology
 Regulatory support

13. Center for Systems Biotechnology
© Fraunhofer

14. Center for Systems Biotechnology
Corporate Management Unit
All Partners
Platform Technologies
FC/IME PUCV/IME UTalca/IME
Aquaculture Energy Agriculture
© Fraunhofer

15. Center for Systems Biotechnology
• CSB established under International Centre of
Excellence (ICE) umbrella.
• Funding provided by INNOVACorfo in Chile and
Fraunhofer Gesellschaft in Germany
• Chilean partners and IME make significant in kind
contributions
• Expected budget approximately $50Mil for 10 years
• Major focus on IP generation and exploitation
© Fraunhofer

16. Center for Systems Biotechnology
• Collaboration between IME staff and Chilean scientist
• Chilean contingent composed of FCR-CSB internal staff
and collaborating co-executors scientists
• Over 40 employees by end of 2011
• Over 35 partner employees dedicated to projects
• Over 20 IME employees dedicated to projects
• Development of platform technologies for innovation
• Developing contacts with industry to identify real needs
© Fraunhofer

17. Center for Systems Biotechnology
Aquaculture
• Collbaroation with Fundacion Chile
• Novel Vaccine Development for salmon disease
• Using IME Production Platform in plants cells
• Markers for early disease detection
• Novel molecular approaches
• Application of technologies to other fish species
• Hake, sea bass,
© Fraunhofer

18. Center for Systems Biotechnology
Bioenergy
• Collaboration with PUCV
• Development of novel biofuel species
• Microalgae, Jatropha, Russian Dandelion
• Providing enginering solutions for extraction of oils,
latex and byproducts from these species
• Life cycle analysis to address sustainability issues
© Fraunhofer

19. Center for Systems Biotechnology
Smart Polymers
• Collaboration with Talca University
• Chemical synthesis of smart polymers
• Synthesis driven by rational design derived from
computational modelling
• Use of polymers to remove unwanted chemicals in
wine and fruit juices
• Database development
© Fraunhofer

20. Center for Systems Biotechnology
Platform Technologies
• Collaboration with PUCV and U Talca
• Bio-Computing
• Bioinformatics for ´omics technologies
• Modelling
• Increasing capacity
• Peptide synthesis for novel therapeutics
• Increasing synergies between partners
© Fraunhofer

21. What we want to develop
Corporate Management Unit
All Partners
Platform Technologies
FC/IME PUCV/IME UTalca/IME TBC/IME TBC/IME
Aquaculture Energy Agriculture Biomining Health
© Fraunhofer

22. Centre of Systems Biotechnology
Forms of IP
• Patent protection
• Trade Mark protection
• Design protection
• Copyright rotection
• Trade and industrial secretsts
•
•
© Fraunhofer

23. Centre of Systems Biotechnology
We will use Trade Secret protection
• In business areas where services are provided
• In areas in of own research
• In areas where relationship with customers
determines that this form of protection is
appropriate
•
•
© Fraunhofer

24. Centre of Systems Biotechnology
We will use patent protection
• in key business areas for platform technology
development
• when patents are required by customers to
improve their business
• to establish new concepts derived from our
research
• as a tool in business negotiations
•
© Fraunhofer

25. Centre of Systems Biotechnology
• Value of having a patent is not in dispute as it allows
exclusivity to develop products
• Having a patent however is of no value per se, unless
its application leads to new product development
and new value generation
• Therefore, field of invention, market knowledge and
process/product value are key
• Two routes identify the right opportunities
•
© Fraunhofer

26. Routes of IP Generation
Two examples from my own life (1)
• Research driven discovery and market creation
• Functional Genomics Research in Tomato
• Development of broad patent portfolio
• Production of novel GM tomato varieties for
processing industry
• Identification of commercial benefit of new
tomatoes
• Sale of product in UK supermarkets
© Fraunhofer

27. Routes of IP Generation
Two examples from my own life (2)
• Market driven discovery
• Develop insect/herbicide resistant maize
• Development of broad patent portfolio
• Identify routes to develop resistance
• Test GM plants for insect/herbicide resistance
• Create market for GM maize varieties
© Fraunhofer

28. Routes of IP Generation
Comparison
• Patenting process identical
• Patenting strategy identical
• Market analysis identical
• Commercial strategies were completely different
• Market driven approach had fewer commercial
uncertainties
© Fraunhofer

29. IP Generation at FCR
• We use both R&D driven and market driven approaches
• For R&D driven process:
• Publication review strategy
• Develop a patenting strategy for broad coverage
• Internal/external background IP review
• Consultation with internal partners for field of
application and potential value of invention
• Apply for patent protection in suitable geographies
© Fraunhofer

30. IP Generation at FCR
• We use both R&D driven and market driven appraoches
• For market driven process:
• Close collaboration with industrial partner
• Internal/external background IP review
• Design a patenting strategy for specific application
• Apply for patent protection in suitable geographies
© Fraunhofer

31. IP Generation at FCR
• FCR does not have in-house patent agent/s
• However, we do have staff with IP experience
• Carry out training in IP searches, analysis and strategic
developments
• We will work with local firms providing IP services well
as overseas companies
• FCR/FG owns IP from platform development
• We will share IP depending on level of compensation
© Fraunhofer

32. IP Generation at FCR
• Publications are key to maintain highest scientific
standing
• IP generation will have incentives
• Entrepreneureal culture will be encouraged
• Partnerships with outsid companbies will be
encouraged
• Spin-offs will be formed based on the body of IP and
market opportunity
© Fraunhofer

33. Summary
• IP generation is central to FCRs activities
• Platform technology development offers many
opportunities for innovation
• Proximity to industry offers many opportunities for
applying this IP and developing additional IP
• Strategy development is essential for success
© Fraunhofer

34. Contact Details
Wolfgang Schuch
General Manager
Fraunhofer Chile Research Foundation
Centre of Systems Biotechnology
Sanches Fonticilla 310, Piso 14
Las Condes, Santiago, Chile
Wolfgang.schuch@fraunhoferchile.cl
56 96 597 9364
© Fraunhofer